• 1
    Yellowlees PM & Ruffin RE. Psychological defenses and coping styles in patients following a life-threatening attack of asthma. Chest. 1989;95:1298 303.
  • 2
    Thompson WL & Thompson TL. Treating depression in asthmatic patients. Psychosomatics. 1984;25:809 12.
  • 3
    Miller BD. Depression and asthma: a potentially lethal mixture. J Allergy Clin Immunol. 1987;80:481 6.
  • 4
    Rubin NJ. Severe asthma and depression. Arch Fam Med. 1993;2:433 40.
  • 5
    Struck RC, Mrazek DA, Fuhrmann GSW, LaBrecque JF. Physiologic and psychological characteristics associated with deaths due to asthma in childhood. JAMA. 1985;254:1193 8.
  • 6
    Allen GM, Hickie I, Gandevia SC, McKenzie DK. Impaired voluntary drive to breathe: a possible link between depression and unexplained ventilatory failure in asthmatic patients. Thorax. 1994; 49:881 4.
  • 7
    Alt HL. Psychiatric aspects of asthma. Chest. 1992;101:S415 S417.
  • 8
    Belloch A, Perpina M, Paredes T, Gimenez A, Compte L, Banos R. Bronchial asthma and personality dimensions: a multifaceted association. J Asthma. 1994;31:161 70.
  • 9
    Rushford N, Tiller JWG, Pain MCF. Perception of natural fluctuations in peak flow in asthma: clinical severity and psychological correlates. J Asthma. 1998;35:251 9.
  • 10
    Wells KB, Stewart A, Hays RD, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA. 1989;262:914 9.
  • 11
    Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions: results from the Medical Outcomes Study. JAMA. 1989;262:907 13.
  • 12
    Janson C, Bjornsson E, Jerker H, Boman G. Anxiety and depression in relation to respiratory symptoms and asthma. Am J Respir Crit Care Med. 1994;149:930 4.
  • 13
    Yellowlees PM & Kalucy RS. Psychobiological aspects of asthma and the consequent research implications. Chest. 1990;97:628 34.
  • 14
    Lyketsos GC, Karabetsos A, Jordanoglou J, Liokis T, Armagianidis A, Lyketsos CG. Personality characteristics and dysthymic states in bronchial asthma. Psychother Psychosom. 1984;41:177 85.
  • 15
    Bukstein DA. Practical approach to the use of outcomes in asthma. Immun Allergy Clin North Am. 1996;16:859 91.
  • 16
    Rose R & Weiss KB. An overview of outcomes measurement in asthma care. Immun Allergy Clin North Am. 1996;16:841 58.
  • 17
    Richards JM & Hemstreet MP. Measures of life quality, role performance and functional status in asthma research. Am J Respir Crit Care Med. 1994;149:S31 S39.
  • 18
    Player R, Richards J, Kohler CL, Woodby LL, Brooks CM, Bailey WC. Scale for assessing functional impairment in adults with asthma. J Asthma. 1994;31:437 44.
  • 19
    Blaiss MS. Outcomes analysis in asthma. JAMA. 1997;278:1874 80.
  • 20
    Van der Molen T, Postma DS, Schreurs JM, Bosveid HEP, Sears MR, Meyboom de Jong B. Discriminative aspects of two generic and two asthma-specific instruments: relation with symptoms, bronchodilator use and lung function in patients with mild asthma. Qual Life Res. 1997;6:353 61.
  • 21
    Guidelines for the Diagnosis and the Management of Asthma Expert Panel Report II. Bethesda, Md: National Asthma Education and Prevention Program; April 1997. NIH publication no 97-4051.
  • 22
    Dales RE, Spitzer WO, Schechter MT, Suissa S. The influence of psychological status on respiratory symptom reporting. Am Rev Respir Dis. 1989;139:1459 63.
  • 23
    National Heart, Lung & Blood Institute. Guidelines for the Diagnosis and Management of Asthma. J Aller Clin Immunol. 1991; 88:435.
  • 24
    Guyatt GH, King DR, Feeny DH, Stubbing D, Goldstein RS. Generic and specific measurement of health-related quality of life in a clinical trial of respiratory rehabilitation. J Clin Epidemiol. 1999;52:187 92.
  • 25
    Gill TM & Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272:619 26.
  • 26
    Kucera CM, Greenberger PA, Yarnold PR, Choy AC, Levenson T. An attempted prospective testing of an asthma severity index and a quality of life survey for 1 year in ambulatory patients with asthma. Allergy Asthma Proc. 1999;20:29 38.
  • 27
    Juniper EF, Guyatt GH, Epstein RS, Ferrie PJ, Jaeschke R, Hiller TK. Evaluation of impairment of health-related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47:76 83.
  • 28
    Malo JL, Boulet LP, Dewitte JD, et al. Quality of life of subjects with occupational asthma. J Allergy Clin Immunol. 1993;91:1121 7.
  • 29
    Juniper EF, Johnston PR, Borkhoff CM, Guyatt GH, Boulet LP, Haukioja A. Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med. 1995; 151:66 70.
  • 30
    Rowe BH & Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis. 1993; 148:675 81.
  • 31
    Rutten-van Molken MPMH, Custers F, Van Doorslaer EKA, et al. Comparison of performance of four instruments in evaluating the effects of salmeterol on asthma quality of life. Eur Respir J. 1995; 8:888 98.
  • 32
    Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma: a randomized, controlled trial. Ann Intern Med. 1999;130:487 95.
  • 33
    Stewart AL, Hays RD, Ware JE. The MOS Short-form General Health Survey: reliability and validity in a patient population. Med Care. 1988;26:724 32.
  • 34
    Ware JE, Kosinski M, Bayliss MS, McHorney CA, Rogers WH, Raczek A. Comparison of methods for scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care. 1995;33: AS264 AS2779.
  • 35
    Bousquet J, Knani J, Dhivert H, et al. Quality of life in asthma: internal consistency and validity of the SF-36 questionnaire. Am J Respir Crit Care Med. 1994;149:371 5.
  • 36
    Mahajan P, Okamoto LJ, Schaberg A, Kellerman D, Schoenwetter WF. Impact of fluticasone propionate powder on health-related quality of life in patients with moderate asthma. J Asthma. 1997; 34:227 34.
  • 37
    Noonan M, Chervinsky P, Busse WW, et al. Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life. Am J Respir Crit Care Med. 1995;152:1467 73.
  • 38
    Yesavage JA & Brink TL. Development and validation of a geriatric depression screening scale: a preliminary report. Psychiatr Res. 1983;17:37 49.
  • 39
    Yellowlees PM, Haynes S, Potts N, Ruffin RE. Psychiatric morbidity in patients with life threatening asthma: initial report of a controlled study. Med J Aust. 1988;149:246 9.
  • 40
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiarty. 1961;4:561 71.
  • 41
    Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. J Appl Psychol Meas. 1977;1: 385 401.
  • 42
    Callahan LF, Kaplan MR, Pincus T. The Beck Depression Inventory, Center for Epidemiological Studies Depression Scale (CES-D), and General Well-Being Schedule Depression subscale in rheumatoid arthritis. Arthritis Care Res. 1991;4:3 11.
  • 43
    Sheikh JI & Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 1986;5:165 73.
  • 44
    Charlson ME, Pompei P, Ales KI, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373 83.
  • 45
    Aaronson NK, Acquadro C, Alonso J, et al. International quality of life assessment (IQOLA) project. Qual Life Res. 1992;1:349 51.
  • 46
    Lang TA & Secic M. How to Report Statistics in Medicine. Philadelphia, Pa: American College of Physicians/BMJ Publishing Group; 1997.
  • 47
    Armitage P & Berry G. Statistical Methods in Medical Research, 3rd ed. Oxford, UK: Blackwell Science Ltd; 1994.
  • 48
    Tukey JW. Exploratory Data Analysis. Reading, Mass: Addison-Wesley; 1977.
  • 49
    Draper NR & Smith H. Applied Regression Analysis. 2nd ed. New York, NY: Wiley; 1981.
  • 50
    Coulehan JL, Schulberg HC, Block MA, Janosky JE, Arena VC. Depressive symptomatology and medical co-morbidity in a primary care clinic. Int J Psychiatry Med. 1990;20:335 47.
  • 51
    Coyne JC, Fechner-Bates S, Schwenk TL. Prevalence, nature, and comorbidity of depressive disorders in primary care. Gen Hosp Psychiatry. 1994;16:267 76.
  • 52
    Katon W, Von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care. 1992;30:67 76.
  • 53
    Bell JR. Underdiagnosis of depression in primary care: by accident or design? JAMA. 1997;277:1433.
  • 54
    Simon GE, Goldberg D, Tiemens BG, Ustun TB. Outcomes of recognized and unrecognized depression in an international primary care study. Gen Hosp Psychiatry. 1999;21:97 105.
  • 55
    Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569 80.
  • 56
    Hirschfeld RM, Keller MB, Panico S, et al. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA. 1997;277:333 40.
  • 57
    Fitzpatrick MF, Engleman H, Whyte KF, Deary IJ, Shapiro CM, Douglas NJ. Morbidity in nocturnal asthma: sleep quality and daytime cognitive performance. Thorax. 1991;46:569 73.